Bedaquiline: Difference between revisions
From IDWiki
No edit summary |
No edit summary |
||
| Line 3: | Line 3: | ||
* Member of the diarylquinoline class of antibiotics |
* Member of the diarylquinoline class of antibiotics |
||
* Adverse events include QT prolongation, hepatitis, and possibly an increased risk of death |
* Adverse events include QT prolongation, hepatitis, and possibly an increased risk of death |
||
| + | ** Others: arthralgias, dizziness, headache, hyperuriemia, insomnia, myalgia, nausea, prolonged ECG QT interval, pruritus, and vomiting |
||
[[Category:Antibiotics]] |
[[Category:Antibiotics]] |
||
Revision as of 10:40, 14 November 2019
- Antituberculosis antibiotic used as second-line therapy
- Inhibits the ATP synthase proton pump in mycobacteria
- Member of the diarylquinoline class of antibiotics
- Adverse events include QT prolongation, hepatitis, and possibly an increased risk of death
- Others: arthralgias, dizziness, headache, hyperuriemia, insomnia, myalgia, nausea, prolonged ECG QT interval, pruritus, and vomiting
